GGrantIndex
← Search

phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma

$439,418P50FY2021CANIH

Northwestern University At Chicago, Evanston IL

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →